Includes level one evidence that MammaPrint can help prevent unnecessary Read More
Late-breaking abstract at the 2022 San Antonio Breast Cancer Symposium Read More
MammaPrint is the only FDA-cleared gene expression test to identify Read More
Demonstrates the ongoing impact of its 10,000-patient FLEX trial to Read More
The LESS study will evaluate reduced endocrine therapy for HR+/HER2- Read More
Data show MammaPrintยฎย is the first and most comprehensive FDA-cleared test Read More
Data demonstrate Research Use Only ImPrint testโs ability to identify Read More
Company to present multiple recent Registry sub-studies driving cancer care Read More
Next-generation sequencing version of MammaPrint and BluePrint enables decentralized testing Read More
Company showcases pipeline developments and sub-studies from the revolutionary FLEX Read More
Contact
For the US, Puerto Rico, Canada
and South America
Agendia Inc. USA, 22 Morgan, Irvine, CA 92618
(888) 321-2732
customercare@agendia.com
For outside the Americas
Agendia NV, Radarweg 60, 1043 NT Amsterdam, The Netherlands
+31 (0)20 462 1510
customerservice@agendia.com
ยฉ2025 Agendia. All rights reserved. MammaPrint and Blueprint are registered trademarks of Agendia, Inc.
CHIEF FINANCIAL OFFICER
Ron Kalfus, our Chief Financial Officer, joined Agendia in July 2025. He has over 20 years of leadership experience in both public and private companies within diagnostics/biotech, and brings extensive knowledge in financial operations and management. Prior to joining Agendia, Ron served as CFO at MDxHealth, Rosetta Genomics, and MabCure. Ron holds a MS in Accounting from Fairleigh Dickinson University and a BBA in Finance from the University of Georgia and is a licensed CPA.
CHIEF COMPLIANCE OFFICER
Stephanie has worked in compliance since 2005 and has extensive experience developing and managing programs to support compliance with global, federal, and state laws and regulations in the healthcare and biotech industries. Prior to joining Agendia, Stephanie spent a significant portion of her career serving as a compliance officer in laboratories, such as HealthTrackRx, NeoGenomics, and Myriad Genetics, and held compliance leadership roles in medical device, pharma, and large health systems.
Stephanie graduated Summa Cum Laude with a B.S. in Healthcare Administration from Northern Illinois University and is Certified in Healthcare Compliance (CHC), Data Privacy (CHP), Research Compliance (CHRC), and is a Certified Internal Auditor (CIA).
